363 related articles for article (PubMed ID: 15936376)
1. Enterobacter meningitis: organism susceptibilities, antimicrobial therapy and related outcomes.
Foster DR; Rhoney DH
Surg Neurol; 2005 Jun; 63(6):533-7; discussion 537. PubMed ID: 15936376
[TBL] [Abstract][Full Text] [Related]
2. Third-generation cephalosporin resistance among Gram-negative bacilli causing meningitis in neurosurgical patients: significant challenges in ensuring effective antibiotic therapy.
O'Neill E; Humphreys H; Phillips J; Smyth EG
J Antimicrob Chemother; 2006 Feb; 57(2):356-9. PubMed ID: 16368699
[TBL] [Abstract][Full Text] [Related]
3. Predictors of in-hospital mortality for bloodstream infections caused by Enterobacter species or Citrobacter freundii.
Deal EN; Micek ST; Ritchie DJ; Reichley RM; Dunne WM; Kollef MH
Pharmacotherapy; 2007 Feb; 27(2):191-9. PubMed ID: 17253909
[TBL] [Abstract][Full Text] [Related]
4. Influence of third-generation cephalosporin resistance on adult in-hospital mortality from post-neurosurgical bacterial meningitis.
Chang CJ; Ye JJ; Yang CC; Huang PY; Chiang PC; Lee MH
J Microbiol Immunol Infect; 2010 Aug; 43(4):301-9. PubMed ID: 20688290
[TBL] [Abstract][Full Text] [Related]
5. Effects of an alternative cefepime dosing strategy in pulmonary and bloodstream infections caused by Enterobacter spp, Citrobacter freundii, and Pseudomonas aeruginosa: a single-center, open-label, prospective, observational study.
Deal EN; Micek ST; Reichley RM; Ritchie DJ
Clin Ther; 2009 Feb; 31(2):299-310. PubMed ID: 19302902
[TBL] [Abstract][Full Text] [Related]
6. Clinical characteristics of Stenotrophomonas maltophilia meningitis in adults: a high incidence in patients with a postneurosurgical state, long hospital staying and antibiotic use.
Huang CR; Chen SF; Tsai NW; Chang CC; Lu CH; Chuang YC; Chien CC; Chang WN
Clin Neurol Neurosurg; 2013 Sep; 115(9):1709-15. PubMed ID: 23611735
[TBL] [Abstract][Full Text] [Related]
7. Clinical characteristics and predictors of mortality in patients with Enterobacter aerogenes bacteremia.
Chang EP; Chiang DH; Lin ML; Chen TL; Wang FD; Liu CY
J Microbiol Immunol Infect; 2009 Aug; 42(4):329-35. PubMed ID: 19949757
[TBL] [Abstract][Full Text] [Related]
8. The clinical relevance of Enterobacter infections.
Shlaes DM
Clin Ther; 1993; 15 Suppl A():21-8. PubMed ID: 8513457
[TBL] [Abstract][Full Text] [Related]
9. Antibiotic therapy for enterobacter meningitis: a retrospective review of 13 episodes and review of the literature.
Wolff MA; Young CL; Ramphal R
Clin Infect Dis; 1993 Jun; 16(6):772-7. PubMed ID: 8329509
[TBL] [Abstract][Full Text] [Related]
10. Enterobacter bacteremia: Clinical features, risk factors for multiresistance and mortality in a Chinese University Hospital.
Ye Y; Li JB; Ye DQ; Jiang ZJ
Infection; 2006 Oct; 34(5):252-7. PubMed ID: 17033748
[TBL] [Abstract][Full Text] [Related]
11. [Phenotypic and genotypic characterization of resistance to third-generation cephalosporins in Enterobacter spp].
Bertona E; Radice M; Rodríguez CH; Barberis C; Vay C; Famiglietti A; Gutkind G
Rev Argent Microbiol; 2005; 37(4):203-8. PubMed ID: 16502641
[TBL] [Abstract][Full Text] [Related]
12. Relationship between ceftriaxone use and resistance to third-generation cephalosporins among clinical strains of Enterobacter cloacae.
Muller A; Lopez-Lozano JM; Bertrand X; Talon D
J Antimicrob Chemother; 2004 Jul; 54(1):173-7. PubMed ID: 15150164
[TBL] [Abstract][Full Text] [Related]
13. Treatment of bacterial meningitis: an overview of Cochrane systematic reviews.
Prasad K; Karlupia N; Kumar A
Respir Med; 2009 Jul; 103(7):945-50. PubMed ID: 19375903
[TBL] [Abstract][Full Text] [Related]
14. Nosocomial enterobacter meningitis: risk factors, management, and treatment outcomes.
Parodi S; Lechner A; Osih R; Vespa P; Pegues D
Clin Infect Dis; 2003 Jul; 37(2):159-66. PubMed ID: 12856206
[TBL] [Abstract][Full Text] [Related]
15. [Resistance to third generation cephalosporins in Sfax hospitals, Tunisia (1999-2005)].
Mkaouar D; Mahjoubi F; Mezghani S; Znazen A; Ktari S; Hammami A
Med Mal Infect; 2008 Jun; 38(6):293-8. PubMed ID: 18191516
[TBL] [Abstract][Full Text] [Related]
16. [Successful treatment of a patient with multidrug resistant Acinetobacter baumannii meningitis with high dose ampicillin-sulbactam].
Sayin Kutlu S; Saçar S; Süzer T; Cevahir N; Okke D; Dirgen Caylak S; Turgut H
Mikrobiyol Bul; 2008 Apr; 42(2):353-8. PubMed ID: 18697435
[TBL] [Abstract][Full Text] [Related]
17. Differences in the changes in resistance patterns to third- and fourth-generation cephalosporins and piperacillin/tazobactam among Klebsiella pneumoniae and Escherichia coli clinical isolates following a restriction policy in a Greek tertiary care hospital.
Petrikkos G; Markogiannakis A; Papaparaskevas J; Daikos GL; Stefanakos G; Zissis NP; Avlamis A
Int J Antimicrob Agents; 2007 Jan; 29(1):34-8. PubMed ID: 17189092
[TBL] [Abstract][Full Text] [Related]
18. Impact of previous use of antibiotics on development of resistance to extended-spectrum cephalosporins in patients with enterobacter bacteremia.
Lee SO; Kim YS; Kim BN; Kim MN; Woo JH; Ryu J
Eur J Clin Microbiol Infect Dis; 2002 Aug; 21(8):577-81. PubMed ID: 12226687
[TBL] [Abstract][Full Text] [Related]
19. Restriction of third-generation cephalosporin use decreases infection-related mortality.
Du B; Chen D; Liu D; Long Y; Shi Y; Wang H; Rui X; Cui N
Crit Care Med; 2003 Apr; 31(4):1088-93. PubMed ID: 12682477
[TBL] [Abstract][Full Text] [Related]
20. Nosocomial meningitis caused by Enterobacteriaceae: risk factors and outcome in 18 cases in 1992-2007.
Benca J; Ondrusova A; Rudinsky B; Bauer F; Kovac M
Neuro Endocrinol Lett; 2007 Jun; 28 Suppl 2():27-9. PubMed ID: 17558373
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
